Page 42 - Biomarkers for risk stratification and guidance in heart failure

Multimarker risk score in emergency department dyspnea
36. de Boer RA, van Veldhuisen DJ, Gansevoort RT, Muller Kobold AC, van Gilst WH, Hillege HL, Bakker SJL, van der Harst P. The fibrosis marker galectin-3 and outcome in the general population: Data from prevend. Journal of Internal Medicine. 2011
37. Lok DJA, Van Der Meer P, de la Porte PWBA, Lipsic E, Van Wijngaarden J, Hillege HL, van Veldhuisen DJ. Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: Data from the deal-hf study. Clinical research in cardiology. 2010;99:323-328
38. Felker GM, Fiuzat M, Shaw LK, Clare R, Whellan DJ, Bettari L, Shirolkar SC, Donahue M, Kitzman DW,
Zannad F. Galectin-3 in ambulatory patients with heart failure: Results from the hf-action study. 2 Circulation: Heart Failure. 2011
39. Shah RV, Chen-Tournoux AA, Picard MH, van Kimmenade RRJ, Januzzi JL. Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure. European Journal of Heart Failure. 2010;12:826-832
40. Grubb AO. Cystatin c-properties and use as diagnostic marker. Advances in clinical chemistry. 2001;35:63-99
41. Lassus J, Harjola VP, Sund R, Siirilä-Waris K, Melin J, Peuhkurinen K, Pulkki K, Nieminen MS. Prognostic value of cystatin c in acute heart failure in relation to other markers of renal function and nt-probnp. European heart journal. 2007;28:1841
42. Sarnak MJ, Katz R, Stehman-Breen CO, Fried LF, Jenny NS, Psaty BM, Newman AB, Siscovick D, Shlipak MG. Cystatin c concentration as a risk factor for heart failure in older adults. Annals of internal medicine.142 %
43. Januzzi JL, Van Kimmenade R, Lainchbury J, Bayes-Genis A, Ordonez-Llanos J, Santalo-Bel M, Pinto YM, Richards M. Nt-probnp testing for diagnosis and short-term prognosis in acute destabilized heart failure: An international pooled analysis of 1256 patients. European heart journal. 2006;27:330
44. Januzzi JL, Camargo CA, Anwaruddin S, Baggish AL, Chen AA, Krauser DG, Tung R, Cameron R, Nagurney JT, Chae CU. The n-terminal pro-bnp investigation of dyspnea in the emergency department (pride) study. The American journal of cardiology. 2005;95:948-954
45. Medina AM, Marteles MS, Sáiz EB, Martínez SS, Laiglesia FR, Rodríguez JAN, Pérez-Calvo JI. Prognostic utility of nt-probnp in acute exacerbations of chronic pulmonary diseases. European Journal of Internal Medicine. 2011
46. Stolz D, Breidthardt T, Christ-Crain M, Bingisser R, Miedinger D, Leuppi J, Mueller B, Tamm M, Mueller C. Use of b-type natriuretic peptide in the risk stratification of acute exacerbations of copd*. Chest. 2008;133:1088-1094
47. Steyerberg EW, Eijkemans MJC, Habbema JDF. Stepwise selection in small data sets: A simulation study of bias in logistic regression analysis. Journal of clinical epidemiology. 1999;52:935-942
48. Gage BF, van Walraven C, Pearce L, Hart RG, Koudstaal PJ, Boode B, Petersen P. Selecting patients with atrial fibrillation for anticoagulation. Circulation. 2004;110:2287-2292
49. Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJGM. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach. Chest. 2010;137:263
50. Pisters R, Lane DA, Nieuwlaat R, De Vos CB, Crijns HJGM, Lip GYH. A novel user-friendly score (has-bled) to assess 1-year risk of major bleeding in patients with atrial fibrillation. Chest. 2010;138:1093-1100
51. Maisel A, Mueller C, Nowak R, Peacock WF, Landsberg JW, Ponikowski P, Mockel M, Hogan C, Wu AHB, Richards M. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: Results from the bach (biomarkers in acute heart failure) trial. Journal of the American College of Cardiology. 2010;55:2062-2076
52. McCullough PA, Nowak RM, McCord J, Hollander JE, Herrmann HC, Steg PG, Duc P, Westheim A, Omland T, Knudsen CW. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure. Circulation. 2002;106:416-422
53. Altman DG, Vergouwe Y, Royston P, Moons KGM. Prognosis and prognostic research: Validating a prognostic model. Bmj. 2009;338
41